Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia
Status:
Completed
Trial end date:
2020-02-17
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of Rheosorbilact®, solution for infusion
("Yuria-Pharm" LLC), in comparison with Ringer's Lactate, solution for infusion, in a complex
therapy of pneumonia. Half of participants will receive Rheosorbilact® in complex therapy,
while the other half will receive Ringer's Lactate in complex therapy.